Biofrontera AG BIFRF
OTC PK
| 06/30/2026 | 03/31/2026 | 09/30/2025 | 09/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | 12.27M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | 12.27M |
| Cost of Revenue | -- | -- | -- | -- | 1.45M |
| Gross Profit | -- | -- | -- | -- | 10.82M |
| SG&A Expenses | -- | -- | -- | -- | 9.95M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -- | -- | -- | -- | 12.34M |
| Operating Income | -- | -- | -- | -- | -68.10K |
| Income Before Tax | -- | -- | -- | -- | 1.57M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -- | -- | -- | -- | 4.23 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | 951.30K |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -- | -- | -- | -- | -886.70K |
| EBIT | -- | -- | -- | -- | -68.10K |
| EBITDA | -- | -- | -- | -- | 302.30K |
| EPS Basic | -- | -- | -- | -- | -0.85 |
| Normalized Basic EPS | -- | -- | -- | -- | -0.28 |
| EPS Diluted | -- | -- | -- | -- | -0.85 |
| Normalized Diluted EPS | -- | -- | -- | -- | -0.28 |
| Average Basic Shares Outstanding | -- | -- | -- | -- | 20.88M |
| Average Diluted Shares Outstanding | -- | -- | -- | -- | 20.88M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |